FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies
Go back to FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies| Gilead Sciences (NASDAQ: GILD) | Delayed: 145.68 -3.18 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.86 | 52 Week High | $108.63 | |||
| Open | $149.47 | 52 Week Low | $71.39 | |||
| Day High | $149.47 | P/E | 80.49 | |||
| Day Low | $144.88 | EPS | $1.81 | |||
| Volume | 3,903,775 | |||||
